Shenzhen Bioeasy Biotechnology Co. Ltd.

Shenzhen Bioeasy Biotechnology Co. Ltd.

300942 · SHE · Healthcare / Biotechnology

5.66CNY-0.15 (-2.58%)

Price History

Full chart

Market Stats

Previous Close5.81
Open5.85
Day Range5.64 – 5.93
52-Week Range5.55 – 11.46
Volume3.34M
Market Cap2.69B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.37%
Beta0.53
50-Day Avg6.51
200-Day Avg7.87

About

Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food safety testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatment column, certified reference, and quality control. It also provides specialized solutions, which include multi-mode precision detection, project plan for specialized equipment, AI-powered fully automated grain comprehensive testing workstation, digital food safety automatic detection, rapid testing laboratory, smart supervision, and comprehensive solution for rapid testing. In addition, the company offers software platforms, such as smart grain depot, traceability, orchard, datian, tea garden, and park project, as well as digital village project and agricultural and rural data projects. Its products are used in dairy, cereal and feed, fruit and vegetable, meat and seafood, honey and egg, laboratory, animal health, and other industries. The company was founded in 2007 and is headquartered in Shenzhen, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhaoli Xiao
  • Employees542
  • HeadquartersA101, Building 2, Shenzhen, China, 518126, China
  • Websitehttps://www.bioeasy.com

Leadership

  • Mr. Zhaoli XiaoChairman & GM · b. 1974
  • Mr. Guangsheng WangFinancial Director · b. 1980
  • Ms. Wentian LiDeputy GM, Secretary & Non-Independent Director · b. 1992
  • Mr. Jin Long ZhangDeputy General Manager · b. 1976
  • Rui Jie ZhangAccounting Supervisor

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue87.05M137.89M204.93M239.18M258.46M597.54M686.90M254.11M224.25M263.23M
Growth (%)-+58.41%+48.62%+16.71%+8.06%+131.20%+14.95%-63.01%-11.75%+17.38%
Cost of Revenue22.23M34.29M64.47M66.08M76.73M171.38M345.01M157.92M68.15M94.81M
Gross Profit64.82M103.59M140.46M173.10M181.73M426.16M341.89M96.19M156.10M168.42M
Gross Margin74.47%75.13%68.54%72.37%70.31%71.32%49.77%37.85%69.61%63.98%
Operating Expense48.34M59.14M55.66M67.86M106.62M157.88M243.78M271.49M135.14M141.98M
Operating Income16.48M44.46M84.80M105.24M75.10M268.28M98.11M-175.30M20.96M26.44M
Operating Margin18.93%32.24%41.38%44.00%29.06%44.90%14.28%-68.99%9.35%10.04%
EBITDA30.57M48.51M89.24M110.83M79.83M279.43M110.65M-151.09M51.84M69.66M
EBITDA Margin35.12%35.18%43.55%46.34%30.89%46.76%16.11%-59.46%23.12%26.46%
Net Income23.44M39.29M73.94M92.31M65.45M236.51M82.97M-184.91M17.12M13.74M
Net Income Margin26.93%28.50%36.08%38.59%25.32%39.58%12.08%-72.77%7.63%5.22%
R&D16.90M23.96M24.42M33.69M40.46M72.43M111.42M53.14M40.45M41.45M
R&D as % of Total Revenue19.42%17.37%11.92%14.08%15.66%12.12%16.22%20.91%18.04%15.75%
Interest Expense77.88K9.99K76.90K56.89K776.75K3.00M4.30M10.80M18.83M26.49M
Interest Expense % of Total Revenue0.09%0.01%0.04%0.02%0.30%0.50%0.63%4.25%8.40%10.06%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets123.07M173.80M296.83M619.67M652.89M1.15B1.28B1.36B1.46B1.52B
Total Liabilities67.83M59.19M74.22M91.35M103.90M205.94M317.75M507.61M586.92M616.87M
Total Equity55.26M114.65M222.69M528.39M549.05M944.76M964.89M848.99M869.01M904.08M
Cash69.22M99.49M189.34M442.27M379.10M342.21M247.45M481.75M293.40M392.84M
Total Debt----54.09M41.12M119.34M351.12M467.98M-
Net Debt-69.22M-99.49M-189.34M-442.27M-325.01M-301.09M-128.11M-115.88M132.99M41.16M

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow36.31M23.60M57.93M67.24M63.79M255.42M152.55M-37.25M34.26M66.87M
Investing Cash Flow-8.97M-10.37M-8.95M-19.68M-73.82M-426.57M-189.95M-66.23M-347.52M-
Financing Cash Flow-17.05M34.10M209.28M-46.23M140.64M-53.85M333.13M87.14M-
Capital Expenditure9.03M10.82M10.53M26.29M82.84M79.51M176.85M128.64M174.10M45.90M
Free Cash Flow27.29M12.79M47.40M40.95M-19.04M175.92M-24.29M-165.89M-139.85M20.97M
Dividends Paid-28.00M28.00M7.00M45.00M18.04M99.81M12.94M5.34M13.86M
FCF to OCF75.14%54.17%81.82%60.90%-29.85%68.87%-15.92%445.36%-408.21%31.36%
Dividend Paid to FCF-219.00%59.07%17.09%-236.31%10.25%-410.86%-7.80%-3.82%66.07%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------
EPS Actual0.220.190.080.100.280.09-0.01-0.16-0.07-0.10-0.07-0.21-0.020.010.010.03-0.010.010.04-0.01-0.03-0.02
Surprise----------------------
Timing----------------------

Key Statistics & Ratios

Market Cap2.69B
Enterprise Value2.56B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.54
Price / Book3.06
EPS-0.02
Book Value2.16
Revenue (TTM)282.31M
Gross Profit (TTM)171.18M
EBITDA44.04M
Profit Margin-2.95%
Operating Margin0.42%
Return on Equity-0.67%
Return on Assets0.36%
Shares Outstanding405.08M
Shares Float150.35M
Beta0.53
Dividend Yield0.37%
Dividend Rate0.02
Payout Ratio134.15%

Dividends

20261×
0.02Jun 3, 2026
20251×
0.02May 28, 2025
20231×
0.02May 31, 2023
20221×
0.25May 30, 2022
20211×
0.04Jun 2, 2021